KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Manhattan Associates (MANH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Manhattan Associates (MANH) over the last 17 years, with Q3 2025 value amounting to $263.6 million.

  • Manhattan Associates' Cash & Equivalents rose 2261.11% to $263.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.6 million, marking a year-over-year increase of 2261.11%. This contributed to the annual value of $266.2 million for FY2024, which is 166.62% down from last year.
  • Latest data reveals that Manhattan Associates reported Cash & Equivalents of $263.6 million as of Q3 2025, which was up 2261.11% from $230.6 million recorded in Q2 2025.
  • Manhattan Associates' Cash & Equivalents' 5-year high stood at $270.7 million during Q4 2023, with a 5-year trough of $153.3 million in Q2 2023.
  • Over the past 5 years, Manhattan Associates' median Cash & Equivalents value was $213.8 million (recorded in 2022), while the average stood at $218.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 16191.37% in 2021, then crashed by 2829.06% in 2023.
  • Over the past 5 years, Manhattan Associates' Cash & Equivalents (Quarter) stood at $263.7 million in 2021, then decreased by 14.5% to $225.5 million in 2022, then increased by 20.08% to $270.7 million in 2023, then decreased by 1.67% to $266.2 million in 2024, then fell by 1.0% to $263.6 million in 2025.
  • Its Cash & Equivalents stands at $263.6 million for Q3 2025, versus $230.6 million for Q2 2025 and $205.9 million for Q1 2025.